Effectiveness of Budesonide Nasal Instillation in a Vertex-to-floor Position
NCT02862509 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2016-08-19
Summary
o Chronic rhinosinusitis is one of the most common health issue affected American population. Surgery plays an important role in the patients who failed the medical treatment. The most difficult location to be operated endoscopically is the frontal sinus. Frontal sinus is also found to be one of the most common sinus for residual and recurrence after the operation. Intranasal steroid seems to be one of the most beneficent post-sinus surgery cares. The topical therapy can be delivered by many approaches. According to the standard clinical practice guideline and recommendations, intranasal corticosteroid spray is suggested. The technique proved to have greater distribution than standard intranasal spray is instillation of steroid nose drops. The head position for instillation of steroid nose drops proven to have a greater access to olfactory cleft and frontal area is Vertex-to-floor position.
Conditions
- Chronic Frontal Rhinosinusitis
- Vertex to Floor Position
Interventions
- DRUG
-
Budesonide nasal instillation
- DRUG
-
Normal saline nasal instillation
Sponsors & Collaborators
-
Khon Kaen University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2017-08-31
- Completion
- 2017-08-31
Countries
- Thailand
Study Locations
More Related Trials
-
Efficacy and Safety of Budesonide Inhalation Suspension for the Treatment of Chronic Rhinosinusitis With Polyposis.
NCT03687515 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Budesonide Intrapolyp Injection in CRSwNP
NCT05474924 ·Status: UNKNOWN ·Phase: PHASE4
-
The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis
NCT05931744 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Use of Budesonide Diluted to Maximum Clinical Treatment of Patients With Chronic Rhinosinusitis With Polyoposis.
NCT05541419 ·Status: UNKNOWN ·Phase: NA
-
Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery
NCT01814618 ·Status: WITHDRAWN ·Phase: PHASE2
-
Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome
NCT00560586 ·Status: COMPLETED ·Phase: PHASE4
-
Nebulized Nasal Steroids
NCT07270302 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
The Long-Term Safety of Budesonide for Patients With Chronic Rhinosinusitis
NCT03584178 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Topical Therapies in Post op Endoscopic Sinus Surgery Patients
NCT03303677 ·Status: WITHDRAWN ·Phase: PHASE3
-
Assessing Improvement in Cognitive Deficit in CRS in Patients Treated With Medical Vs Surgical Management
NCT04291118 ·Status: UNKNOWN ·Phase: NA
-
Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity
NCT04361474 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)
NCT05882903 ·Status: RECRUITING ·Phase: PHASE2
-
Role of Montelukast in the Management of Chronic Rhinosinusitis With Nasal Polyps.
NCT05143502 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
NasoNeb Delivery of an Intranasal Steroid
NCT01270256 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Complication of Gentamicin Nasal Irrigation in Chronic Rhinosinusitis and Recurrent Sinusitis
NCT02582099 ·Status: UNKNOWN ·Phase: PHASE4
-
Endoscopic Sinus Surgery for Refractory Chronic Sinusitis
NCT02506426 ·Status: UNKNOWN ·Phase: NA
-
Mometasone vs Budesonide in CRS With Polyposis
NCT03323866 ·Status: TERMINATED ·Phase: PHASE3
-
Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety
NCT01622569 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Asthma and Nasal Steroids
NCT01118312 ·Status: COMPLETED ·Phase: PHASE4
-
Nasal Obstruction With Oxymetazoline and Corticosteroids
NCT06830109 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of Modified Olfactory Training on Postoperative Olfactory Dysfunction in Patients With CRS
NCT06837051 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Nasal Steroids in Snoring Intensity
NCT01849406 ·Status: COMPLETED ·Phase: PHASE1
-
Smell in Covid-19 and Efficacy of Nasal Theophylline
NCT04789499 ·Status: COMPLETED ·Phase: PHASE2
-
Itraconazole for Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps
NCT02285283 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
NCT07168148 ·Status: TERMINATED ·Phase: PHASE2